Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015

Clinical trial NCT01125917 · TERMINATED

Trial details

NCT number: NCT01125917
Sponsor: Purdue Pharma LP
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Back Pain Lower Back Chronic

Start date: 2004-06-01
Primary completion: 2005-09-01
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.